CAS 1256565-36-2

PTC299

CAS: 1256565-36-2

PTC299 ((4-chlorophenyl) (1S)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate) is an orally active inhibitor of VEGFA mRNA

Formel: C₂₅H₂₀Cl₂N₂O₃

Reinheit: 99.72%

Farbe und Form: Solid

Molekulargewicht: 467.34

Ref: TM-T12574

PTC 299

CAS: 1256565-36-2

Formel: C₂₅H₂₀Cl₂N₂O₃

Reinheit: %

Molekulargewicht: 467.3439

Ref: IN-DA01V5RH

PTC299

CAS: 1256565-36-2

PTC299

Reinheit: ≥98%

Molekulargewicht: 467.34g/mol

Ref: 54-BUP04907

4-CHLOROPHENYL (S)-6-CHLORO-1-(4-METHOXYPHENYL)-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOLE-2-CARBOXYLATE

CAS: 1256565-36-2

Reinheit: 99+%

Molekulargewicht: 467.3500061

Ref: 10-F843852

PTC 299

Kontrolliertes Produkt

CAS: 1256565-36-2

Formel: C₂₅H₂₀Cl₂N₂O₃

Farbe und Form: Neat

Molekulargewicht: 467.344

Ref: TR-P125650

PTC299

CAS: 1256565-36-2

PTC299 is a monoclonal antibody that binds to the CD20 protein on the surface of lymphocytes. This binding prevents CD20 from transmitting signals, leading to apoptotic cell death. PTC299 has been shown to be effective in treating chronic lymphocytic leukemia and eye disorders. The most common side effects are headache, nausea, vomiting, diarrhea, dizziness, and fatigue.

Formel: C₂₅H₂₀Cl₂N₂O₃

Reinheit: Min. 95%

Molekulargewicht: 467.3 g/mol

Ref: 3D-GAC56536